Ono Pharmaceutical Co Ltd 2020 Sustainability Report
The report describes ONO's materiality process and priority sustainability issues, including selected SDG contributions. For FY2019, it reports a 8.4% reduction in market-based Scope 1 and 2 GHG emissions compared with FY2017 and a renewable energy usage rate of 11.2%. It also details water-use reduction, resource-recycling activities and human-rights due diligence. Sustainability information in the report received limited assurance from Deloitte Tohmatsu Sustainability Co., Ltd. under ISAE 3000 and ISAE 3410.
Company: Ono Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2020
Type: Sustainability Report
Pages: 109
Back to company
Ono Pharmaceutical Co Ltd
CSR Report
The report describes ONO's materiality process and priority sustainability issues, including selected SDG contributions. For FY2019, it reports a 8.4% reduction in market-based Scope 1 and 2 GHG emissions compared with FY2017 and a renewable energy usage rate of 11.2%. It also details water-use reduction, resource-recycling activities and human-rights due diligence. Sustainability information in the report received limited assurance from Deloitte Tohmatsu Sustainability Co., Ltd. under ISAE 3000 and ISAE 3410.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Apr 1, 2019 - Mar 31, 2020
Fiscal Year
2019
Published
Sep 1, 2020
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Net Zero Target
Employees